UPDATE : Wednesday, August 21, 2019
[ASCO 2019] 'Ibrance brings hopes to neglected premenopausal breast cancer patients'
CHICAGO, Ill. -- A Korean study has shown that Pfizer's Ibrance extends...
by Lee Han-soo, KBR Corresponden  |  2019-06-05 11:33
[ASCO 2019]'Belvarafenib confirms efficacy for solid cancer without approved treatment'
CHICAGO, Ill. -- Belvarafenib, developed by Hanmi Pharmaceutical, has demon...
by Lee Han-soo, KBR Correspondent  |  2019-06-05 11:29
Seoul holds policy consultation with WHO
The Ministry of Health and Welfare and the delegation from the World Health...
by Kwak Sung-sun  |  2019-06-04 17:35
8 out of 10 Korean doctors wish to leave the country
Eight out of 10 doctors in Korea want to leave for another country to work ...
by Song Soo-youn  |  2019-06-04 15:28
[Special] Doctors skeptical about AI-based precision medicine ‘Dr. Answer’
As IBM’s Watson for Oncology rapidly lost popularity among the local medica...
by Kim Eun-young  |  2019-06-04 14:42
FDA OKs phase-1 trial for Yuhan’s investigational lung cancer drug
Yuhan Corp. is gearing up to develop a new lung cancer drug Lazertinib (YH2...
by Jeong Sae-im  |  2019-06-04 14:21
‘Indoor radon exposure raises tumor mutation in lung cancer patients’
Indoor radon exposure increases tumor gene mutation in non-smoking patients...
by Park Gi-taek  |  2019-06-04 14:19
[ASCO 2019] ‘Ontruzant demonstrates equal quality to original drug’
CHICAGO, Ill. -- Samsung Bioepis has proved its quality control ability, as...
by Lee Han-soo, KBR correspondent  |  2019-06-04 14:17
‘New embolization technique can treat brain aneurysm’
A Korean research team said they found a new embolization technique to trea...
by Kwak Sung-sun  |  2019-06-03 16:23
[ASCO 2019] ‘POLO study opens a new era for treating pancreatic cancer patients’
CHICAGO, Ill. -- AstraZeneca and MSD, also known as Merck & Co. inside the ...
by Lee Han-soo, KBR corresponden  |  2019-06-03 16:18
Kolon’s minority shareholders demand over ₩25 billion in damage
Minority shareholders of Kolon Life Science and its subsidiary Kolon Tissue...
by Jeong Sae-im  |  2019-06-03 14:53
Invossa inventor sold Kolon shares at highest value
Former Kolon TissueGene CEO Lee Kwan-hee, the inventor of now-suspended gen...
by Jeong Sae-im  |  2019-06-03 14:52
[ASCO 2019]Novartis’ Kisqali aims to make comeback with new trial results
CHICAGO, Ill. -- Novartis Kisqali, a cyclin-dependent kinase (CDK) 4/6 inhi...
by Lee Han-soo, KBR correspondent  |  2019-06-03 13:41
[Photo News]Scenes at ASCO 2019
CHICAGO, Ill. -- The American Society of Clinical Oncology (ASCO) 2019 has ...
by Lee Han-soo, KBR correspondent  |  2019-06-03 11:58
[ASCO 2019]Korea expanding presence in global oncology field
CHICAGO, Ill. -- American Society of Clinical Oncology (ASCO) 2019 kicked o...
by Lee Han-soo, KBR correspondent  |  2019-06-03 11:17
[ASCO 2019]Roche CEO unveils his company’s future direction at ASCO 2019
CHICAGO, Ill. -- Roche Pharmaceuticals is one of is the largest healthcare ...
by Lee Han-soo, KBR correspondent  |  2019-06-03 11:09
[ASCO 2019]'Asia vital region for Roche’
CHICAGO, Ill. -- The American Society of Clinical Oncology (ASCO) is one of...
by Lee Han-soo, KBR correspondent  |  2019-06-03 11:01
Hanmi’s hypertension drug was effective in phase-4 study 
Hanmi Pharmaceutical’s new combination drug Amosartan (losartan/amlodipine)...
by Jeong Sae-im  |  2019-05-31 16:05
Until when will Kolon keep lying about Invossa?
Kolon Life Science’s “explanations” about the mislabeling of the cell ingre...
by Jeong Sae-im  |  2019-05-31 14:59
Samsung BioLogics agrees to manufacture CytoDyn’s HIV drug
Samsung BioLogics said it has signed a deal with U.S. biotech firm CytoDyn ...
by Jeong Sae-im  |  2019-05-31 14:59
Back to Top